Pharmaceutical Industry News
Trump wants cheaper drugs like Europe has. How it works.
The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why that isn’t a good idea.
3 min read12 Jun 2025‘Fairness to America’: Donald Trump vows to cut drug costs by matching prices paid in other countries
Trump announced an executive order to reduce medication costs for Medicare beneficiaries by linking prices to those in other countries. The proposal aims to address the high cost of prescription drugs but may face opposition from the pharmaceutical industry.
2 min read12 May 2025Genetics can spike Indians' cholesterol, but relief may be at hand
Novartis drug Pelacarsen that targets Lp(a) cholesterol is in global phase 3 trials. Last year, the company launched cholesterol-lowering drug Inclisiran in India under brand name Sybrava. Eli Lilly is working on Lepodisiran, while Amgen is also doing trials for Olpasiran.
6 min read14 Apr 2025Indian pharma turns to home remedy as tariff malady looms
US market exposure limits Indian pharma's safe-haven appeal amid global volatility and tariff fears, but drugmakers focused on domestic markets can officer investors a potential hedge against uncertainty
4 min read10 Apr 2025For small drugmakers playing fast and loose with quality, trouble is on way
The stringent action is meant to prevent criticism of quality of drugs produced in the country and to prevent any non-tariff barriers to Indian drug exports
3 min read20 Mar 2025A winning horse: Why India’s top generics players are rushing to launch this blockbuster diabetes drug
Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney risks, holds significant promise for volume growth as it becomes more affordable.
4 min read13 Mar 2025Pharma department seeks report on drug misuse, eyes NDPS Act inclusion
The department wants to collate data and review these medications in order to bring them under the Narcotic Drugs and Psychotropic Substances Act
3 min read14 Jun 2024Here’s How Medicare Should Negotiate Drug Prices
The federal health-insurance system is finally wielding its leverage to reduce prices. There’s just one problem.
3 min read17 Apr 2024Can a Big Pharma Ever Be Worth $1 Trillion?
Eli Lilly is blowing past its competitors, thanks to prescient bets on obesity and Alzheimer’s. Can it avoid the patent cliff?
4 min read29 Nov 2023Q1 results preview: Here's why pharma companies are expected to show improvement
Nuvama Institutional Equities expects better Q1FY24 results for pharmaceutical companies, with revenue and EBITDA growth predicted to be 16%/30% YoY and 4%/7% QoQ, respectively.
4 min read11 Jul 2023Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared